The use of preliminary scientific evidence in public health: a case study of XMRV.
Kumanan Wilson and colleagues explain how the rapid response to XMRV as a novel pathogen has highlighted some challenges pertaining to policy-making and editorial responsibilities. The impact on policy and the propagation of the initial scientific information may not cease if the evidence is disprov...
Main Authors: | Kumanan Wilson, Katherine Atkinson, Jennifer Keelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-04-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3979645?pdf=render |
Similar Items
-
The XMRV virus: reality and artefactuality in scientific controversy
by: Campbell, Jonah
Published: (2012) -
No evidence for XMRV nucleic acids, infectious virus or anti-XMRV antibodies in Canadian patients with chronic fatigue syndrome.
by: Imke Steffen, et al.
Published: (2011-01-01) -
Social Media and the Empowering of Opponents of Medical Technologies: The Case of Anti-Vaccinationism
by: Wilson, Kumanan, et al.
Published: (2013-05-01) -
No evidence for XMRV association in pediatric idiopathic diseases in France
by: Sitbon Marc, et al.
Published: (2010-08-01) -
Mechanism for XMRV neurotoxicity
by: Miller A Dusty, et al.
Published: (2011-10-01)